Mometason Glenmark (Mometasone Furoate)

Mometasone furoate exerts its effect by binding to glucocorticoid receptors inside skin cells. The drug‑receptor complex then influences gene transcription, suppressing the production of inflammatory mediators like cytokines, prostaglandins and leukotrienes, which results in reduced inflammation and immune response at the site of application.

The dosage of Mometason Glenmark is determined by the prescribing clinician based on the specific condition, severity, patient age and the area of skin to be treated. Patients should follow the healthcare professional’s instructions regarding the amount to apply, frequency and duration of therapy.

Safety data for topical mometasone furoate in pregnancy and lactation are limited. Healthcare providers generally weigh the potential benefits against possible risks before prescribing. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss any concerns with their physician before using the product.

To place an order, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Mometason Glenmark contains mometasone furoate, a high‑potency corticosteroid that offers strong anti‑inflammatory activity with relatively low systemic absorption when used as directed. Compared with lower‑potency agents such as hydrocortisone, it may achieve faster symptom control, but it also requires careful monitoring to avoid local adverse effects.

Store Mometason Glenmark at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain stability and potency.

Apply a thin layer of the cream or ointment to clean, dry skin on the affected area, gently rubbing it in until fully absorbed. Follow the prescriber’s instructions regarding frequency—typically once or twice daily—and avoid excessive use or application to large skin surfaces unless advised.

Serious risks include skin atrophy, telangiectasia, and secondary infections such as bacterial, fungal or viral skin infections. Systemic effects like adrenal suppression are rare but can occur with extensive or prolonged use. Patients should report any unusual thinning of the skin, persistent redness, or signs of infection promptly.

Mometason Glenmark should be avoided in individuals with known hypersensitivity to mometasone furoate or any formulation excipients. It is also contraindicated on infected, ulcerated, or broken skin unless directed by a physician, and should be used with caution in children and immunocompromised patients.